Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Pediatrix Medical Group, Inc.MD · Entity 4451 | EVP, Chief Financial Officer | August 09, 2024 | August 13, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Pediatrix Medical Group, Inc.
Report date August 09, 2024 · Filed August 13, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 175,347 |
Ending reported balance
After 2024-08-12 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2024-08-09 · Sale · Disposed 32,562 · Balance 192,785 F1: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices randing from $10.01 to $10.23 for a weighted average sales price of $10.08. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each seperate price within the range set forth in this footnote. Row 2 · 2024-08-12 · Sale · Disposed 17,438 · Balance 175,347 F2: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $10.00 to $10.17 for a weighted average sales price of $10.08. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securiites and Exchange Commission upon request, full information regarding the number of shares sold at each seperate price within the range set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices randing from $10.01 to $10.23 for a weighted average sales price of $10.08. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each seperate price within the range set forth in this footnote.
F2: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $10.00 to $10.17 for a weighted average sales price of $10.08. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securiites and Exchange Commission upon request, full information regarding the number of shares sold at each seperate price within the range set forth in this footnote.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
QUALITY CARE PROPERTIES, INC.
Report date July 26, 2018 · Filed July 27, 2018
Section 16 reporting ended · disclosed 2018-07-27. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-07-26 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2018-07-26 · Disposition to issuer · Disposed 7,525 · Balance 0 F1: Upon the July 26, 2018 closing of the merger (the "Merger") of Quality Care Properties, Inc. ("QCP") with and into Welltower Inc. ("Welltower") in which Welltower acquired all of the outstanding capital stock of QCP, each outstanding share of QCP common stock was converted into the right to receive $20.75 in cash (without interest). |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-07-26 transaction · row 2
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 2 · 2018-07-26 · Disposition to issuer · Disposed 94,596 · Balance 0 F2: Upon the closing of the Merger, each outstanding QCP restricted stock award fully vested and was converted into the right to receive $20.75 in respect of each share subject to the restricted stock award, with the number of shares in respect of awards subject to performance-based vesting conditions determined assuming performance goals were fully satisfied. |
| Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.73 · Expires 2023-12-15 | Direct | 0 |
Reported balance
After 2018-07-26 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-07-26 · Disposition to issuer · Disposed 705,842 · Balance 0 F3: Each stock option represents the right to buy, upon exercise, one share of common stock of QCP. F4: Upon the closing of the Merger, each outstanding QCP option subject to service-based vesting fully vested and was converted into the right to receive, for each share underlying the option, $20.75 less the applicable exercise price of the option. Upon the closing of the Merger, each outstanding QCP option subject to performance-based vesting conditions vested to the extent the applicable stock price hurdle relating to such option was met in connection with the transaction, and was converted into the right to receive, for each share underlying the option, $20.75 less the applicable exercise price of the option. |
| Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.73 · Expires 2023-12-15 | Direct | 0 |
Reported balance
After 2018-07-26 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2018-07-26 · Disposition to issuer · Disposed 240,000 · Balance 0 F3: Each stock option represents the right to buy, upon exercise, one share of common stock of QCP. F5: These QCP options did not vest and were forfeited because the applicable stock price hurdle relating to such option was not met in connection with the Merger. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2019-11-29 | Direct | 0 |
Reported balance
After 2018-07-26 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2018-07-26 · Disposition to issuer · Disposed 67,934 · Balance 0 F6: Each restricted stock unit represents the right to receive, at settlement, one share of common stock of QCP. F7: Upon the closing of the Merger, each outstanding QCP restricted stock unit award fully vested and was converted into the right to receive $20.75 in respect of each share underlying the restricted stock unit award. |
Filing footnotes · ownership attribution and instrument terms
F1: Upon the July 26, 2018 closing of the merger (the "Merger") of Quality Care Properties, Inc. ("QCP") with and into Welltower Inc. ("Welltower") in which Welltower acquired all of the outstanding capital stock of QCP, each outstanding share of QCP common stock was converted into the right to receive $20.75 in cash (without interest).
F2: Upon the closing of the Merger, each outstanding QCP restricted stock award fully vested and was converted into the right to receive $20.75 in respect of each share subject to the restricted stock award, with the number of shares in respect of awards subject to performance-based vesting conditions determined assuming performance goals were fully satisfied.
F3: Each stock option represents the right to buy, upon exercise, one share of common stock of QCP.
F4: Upon the closing of the Merger, each outstanding QCP option subject to service-based vesting fully vested and was converted into the right to receive, for each share underlying the option, $20.75 less the applicable exercise price of the option. Upon the closing of the Merger, each outstanding QCP option subject to performance-based vesting conditions vested to the extent the applicable stock price hurdle relating to such option was met in connection with the transaction, and was converted into the right to receive, for each share underlying the option, $20.75 less the applicable exercise price of the option.
F5: These QCP options did not vest and were forfeited because the applicable stock price hurdle relating to such option was not met in connection with the Merger.
F6: Each restricted stock unit represents the right to receive, at settlement, one share of common stock of QCP.
F7: Upon the closing of the Merger, each outstanding QCP restricted stock unit award fully vested and was converted into the right to receive $20.75 in respect of each share underlying the restricted stock unit award.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 12, 2024 Filed Aug 13, 2024 21:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | SaleCommon Stock | 17,438 | $10.08 | $175,775.04 |
DisclosureSEC source: 0000950170-24-096399 · ownership.xml · nonDerivative · entry 2 Richards C Marc · CIK 0001468881 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,347 F2 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $10.00 to $10.17 for a weighted average sales price of $10.08. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securiites and Exchange Commission upon request, full information regarding the number of shares sold at each seperate price within the range set forth in this footnote. Read SEC document |
| August 09, 2024 Filed Aug 13, 2024 21:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | SaleCommon Stock | 32,562 | $10.08 | $328,224.96 |
DisclosureSEC source: 0000950170-24-096399 · ownership.xml · nonDerivative · entry 1 Richards C Marc · CIK 0001468881 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 192,785 F1 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices randing from $10.01 to $10.23 for a weighted average sales price of $10.08. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each seperate price within the range set forth in this footnote. Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 21:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 95,760 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-068805 · ownership.xml · nonDerivative · entry 1 Richards C Marc · CIK 0001468881 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,347 F1 · kind: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on June 1, 2025, twenty-five percent (25%) of the restricted shares will vest on June 1, 2026 and fifty percent (50%) of the restricted shares will vest on June 1, 2027, subject to the terms of the Plan. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Tax withholdingCommon Stock | 21,428 | $9.15 | $196,066.20 |
DisclosureSEC source: 0001209191-24-004388 · doc4.xml · nonDerivative · entry 1 Richards C Marc · CIK 0001468881 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,587 F1 · kind: Represents 21,428 restricted shares withheld for payment of taxes upon vesting of shares. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Tax withholdingCommon Stock | 9,991 | $15.74 | $157,258.34 |
DisclosureSEC source: 0001209191-23-015672 · doc4.xml · nonDerivative · entry 2 Richards C Marc · CIK 0001468881 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,015 F3 · kind: Represents 9,991 restricted shares withheld for payment of taxes upon vesting of shares. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 45,308 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-015672 · doc4.xml · nonDerivative · entry 1 Richards C Marc · CIK 0001468881 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,006 F1 · kind: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on March 1, 2024, twenty-five percent (25%) of the restricted shares will vest on March 1, 2025 and fifty percent (50%) of the restricted shares will vest on March 1, 2026, subject to the terms of the Plan. F2 · balance_after: Excludes 30,501 previously reported shares of restricted common stock granted to the reporting person pursuant to the Plan in connection with an annual equity award that were forfeited because the performance-based criteria were not achieved. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:01 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Tax withholdingCommon Stock | 6,874 | $23.47 | $161,332.78 |
DisclosureSEC source: 0001209191-22-015594 · doc4.xml · nonDerivative · entry 3 Richards C Marc · CIK 0001468881 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,199 F4 · kind: Represents 6,874 restricted shares withheld for payment of taxes upon vesting of shares. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:01 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 30,501 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015594 · doc4.xml · nonDerivative · entry 2 Richards C Marc · CIK 0001468881 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,073 F3 · kind: Restricted shares granted pursuant to the Plan in connection with an annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 15,251 additional shares based on the achievement of certain performance-based criteria for the twelve months ending December 31, 2022. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will not vest any earlier than in three installments of twenty-five percent (25%) on March 1, 2023, twenty-five percent (25%) on March 1, 2024 and fifty percent (50%) on March 1, 2025, subject to the terms of the Plan. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:01 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 30,502 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015594 · doc4.xml · nonDerivative · entry 1 Richards C Marc · CIK 0001468881 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,572 F1 · kind: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on March 1, 2023, twenty-five percent (25%) of the restricted shares will vest on March 1, 2024 and fifty percent (50%) of the restricted shares will vest on March 1, 2025, subject to the terms of the Plan. F2 · balance_after: Includes 11,429 restricted shares granted pursuant to the Plan in connection with achievement in excess of target of specified performance-based criteria for the performance period from January 1, 2021 through December 31, 2021. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:43 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 28,572 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016905 · doc4.xml · nonDerivative · entry 2 Richards C Marc · CIK 0001468881 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,641 F2 · kind: Restricted shares granted pursuant to the Issuer's Plan, in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on March 1, 2022, twenty-five percent (25%) of the restricted shares will vest on March 1, 2023 and fifty percent (50%) of the restricted shares will vest on March 1, 2024. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:43 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 28,571 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016905 · doc4.xml · nonDerivative · entry 1 Richards C Marc · CIK 0001468881 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,069 F1 · kind: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 14,286 additional shares based on the achievement of certain performance-based criteria for the twelve months ending December 31, 2021. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will not vest any earlier than in three installments of twenty-five (25%) on March 1, 2022, twenty-five (25%) on March 1, 2023 and fifty (50%) on March 1, 2024, subject to the terms of the Plan. Read SEC document |
| July 26, 2018 Filed Jul 27, 2018 17:00 UTC | QUALITY CARE PROPERTIES, INC. QCP · Entity 164714 | Disposition to issuerRestricted Stock Unit · Derivative | 67,934 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001104659-18-047745 · a4.xml · derivative · entry 5 Richards C Marc · CIK 0001468881 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 67,934 shares Expires 2019-11-29 F6 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock of QCP. F7 · kind: Upon the closing of the Merger, each outstanding QCP restricted stock unit award fully vested and was converted into the right to receive $20.75 in respect of each share underlying the restricted stock unit award. F7 · price: Upon the closing of the Merger, each outstanding QCP restricted stock unit award fully vested and was converted into the right to receive $20.75 in respect of each share underlying the restricted stock unit award. F7 · derivative.exercise_date: Upon the closing of the Merger, each outstanding QCP restricted stock unit award fully vested and was converted into the right to receive $20.75 in respect of each share underlying the restricted stock unit award. Read SEC document |
| July 26, 2018 Filed Jul 27, 2018 17:00 UTC | QUALITY CARE PROPERTIES, INC. QCP · Entity 164714 | Disposition to issuerOptions (right to buy) · Derivative | 240,000 | Not disclosed Strike: $15.73 | Not disclosed |
DisclosureSEC source: 0001104659-18-047745 · a4.xml · derivative · entry 4 Richards C Marc · CIK 0001468881 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 240,000 shares Expires 2023-12-15 F3 · derivative.exercise_price: Each stock option represents the right to buy, upon exercise, one share of common stock of QCP. F5 · kind: These QCP options did not vest and were forfeited because the applicable stock price hurdle relating to such option was not met in connection with the Merger. F5 · price: These QCP options did not vest and were forfeited because the applicable stock price hurdle relating to such option was not met in connection with the Merger. F5 · derivative.exercise_date: These QCP options did not vest and were forfeited because the applicable stock price hurdle relating to such option was not met in connection with the Merger. Read SEC document |
| July 26, 2018 Filed Jul 27, 2018 17:00 UTC | QUALITY CARE PROPERTIES, INC. QCP · Entity 164714 | Disposition to issuerOptions (right to buy) · Derivative | 705,842 | Not disclosed Strike: $15.73 | Not disclosed |
DisclosureSEC source: 0001104659-18-047745 · a4.xml · derivative · entry 3 Richards C Marc · CIK 0001468881 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 705,842 shares Expires 2023-12-15 F3 · derivative.exercise_price: Each stock option represents the right to buy, upon exercise, one share of common stock of QCP. F4 · kind: Upon the closing of the Merger, each outstanding QCP option subject to service-based vesting fully vested and was converted into the right to receive, for each share underlying the option, $20.75 less the applicable exercise price of the option. Upon the closing of the Merger, each outstanding QCP option subject to performance-based vesting conditions vested to the extent the applicable stock price hurdle relating to such option was met in connection with the transaction, and was converted into the right to receive, for each share underlying the option, $20.75 less the applicable exercise price of the option. F4 · price: Upon the closing of the Merger, each outstanding QCP option subject to service-based vesting fully vested and was converted into the right to receive, for each share underlying the option, $20.75 less the applicable exercise price of the option. Upon the closing of the Merger, each outstanding QCP option subject to performance-based vesting conditions vested to the extent the applicable stock price hurdle relating to such option was met in connection with the transaction, and was converted into the right to receive, for each share underlying the option, $20.75 less the applicable exercise price of the option. F4 · derivative.exercise_date: Upon the closing of the Merger, each outstanding QCP option subject to service-based vesting fully vested and was converted into the right to receive, for each share underlying the option, $20.75 less the applicable exercise price of the option. Upon the closing of the Merger, each outstanding QCP option subject to performance-based vesting conditions vested to the extent the applicable stock price hurdle relating to such option was met in connection with the transaction, and was converted into the right to receive, for each share underlying the option, $20.75 less the applicable exercise price of the option. Read SEC document |
| July 26, 2018 Filed Jul 27, 2018 17:00 UTC | QUALITY CARE PROPERTIES, INC. QCP · Entity 164714 | Disposition to issuerCommon Stock | 94,596 | $20.75 | $1,962,867.00 |
DisclosureSEC source: 0001104659-18-047745 · a4.xml · nonDerivative · entry 2 Richards C Marc · CIK 0001468881 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: Upon the closing of the Merger, each outstanding QCP restricted stock award fully vested and was converted into the right to receive $20.75 in respect of each share subject to the restricted stock award, with the number of shares in respect of awards subject to performance-based vesting conditions determined assuming performance goals were fully satisfied. Read SEC document |
| July 26, 2018 Filed Jul 27, 2018 17:00 UTC | QUALITY CARE PROPERTIES, INC. QCP · Entity 164714 | Disposition to issuerCommon Stock | 7,525 | $20.75 | $156,143.75 |
DisclosureSEC source: 0001104659-18-047745 · a4.xml · nonDerivative · entry 1 Richards C Marc · CIK 0001468881 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Upon the July 26, 2018 closing of the merger (the "Merger") of Quality Care Properties, Inc. ("QCP") with and into Welltower Inc. ("Welltower") in which Welltower acquired all of the outstanding capital stock of QCP, each outstanding share of QCP common stock was converted into the right to receive $20.75 in cash (without interest). Read SEC document |
| March 22, 2018 Filed Mar 23, 2018 19:37 UTC | QUALITY CARE PROPERTIES, INC. QCP · Entity 164714 | GrantCommon Stock | 29,227 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-019912 · a4.xml · nonDerivative · entry 2 Richards C Marc · CIK 0001468881 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,373 F2 · shares: Represents the number of shares of the Company's restricted common stock granted on March 22, 2018 that are subject solely to service-based vesting conditions. Subject to such conditions, the shares will vest in three equal annual installments beginning on the first anniversary of the grant date. F3 · balance_after: 21,528 of these shares remain subject to service-based vesting requirements and will vest in equal installments on March 8, 2019 and on March 8, 2020. 73,068 of these shares remain subject to the vesting requirements described in footnotes 1 and 2. Read SEC document |
| March 22, 2018 Filed Mar 23, 2018 19:37 UTC | QUALITY CARE PROPERTIES, INC. QCP · Entity 164714 | GrantCommon Stock | 43,841 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-019912 · a4.xml · nonDerivative · entry 1 Richards C Marc · CIK 0001468881 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,146 F1 · shares: Represents the number of shares of restricted common stock of Quality Care Properties, Inc. (the "Company") granted on March 22, 2018 that are subject to service and performance-based vesting conditions. Subject to such conditions, the actual number of shares earned will vest in three equal annual installments, provided that the first vesting date only will be the later of (1) the first anniversary of the grant date and (2) the date on which the performance-based vesting conditions are satisfied. Read SEC document |
| March 08, 2018 Filed Mar 9, 2018 16:59 UTC | QUALITY CARE PROPERTIES, INC. QCP · Entity 164714 | Tax withholdingCommon Stock | 2,987 | $16.66 | $49,763.42 |
DisclosureSEC source: 0001104659-18-016380 · a4.xml · nonDerivative · entry 1 Richards C Marc · CIK 0001468881 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,305 F1 · shares: Shares withheld by the issuer to satisfy tax withholding obligations upon vesting of previously granted performance-based restricted stock of Quality Care Properties, Inc. (the "Company"). F2 · balance_after: 21,528 of these shares remain subject to time vesting requirements and will vest in equal installments on March 8, 2019 and on March 8, 2020. Read SEC document |
| March 08, 2018 Filed Apr 3, 2018 19:54 UTC Amendment | QUALITY CARE PROPERTIES, INC. QCP · Entity 164714 | Tax withholdingCommon Stock | 3,239 | $16.66 | $53,961.74 |
DisclosureSEC source: 0001104659-18-022258 · a4a.xml · nonDerivative · entry 1 Richards C Marc · CIK 0001468881 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,053 F1 · shares: Shares withheld by the issuer to satisfy tax withholding obligations upon vesting of previously granted performance-based restricted stock of Quality Care Properties, Inc. (the "Company"). F2 · balance_after: 21,528 of these shares remain subject to time vesting requirements and will vest in equal installments on March 8, 2019 and on March 8, 2020. Read SEC document |
| March 08, 2017 Filed Mar 10, 2017 19:24 UTC | QUALITY CARE PROPERTIES, INC. QCP · Entity 164714 | GrantCommon Stock | 32,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-011675 · doc1.xml · nonDerivative · entry 1 Richards C Marc · CIK 0001468881 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,292 F1 · shares: Represents maximum number of shares of common stock of Quality Care Properties, Inc. that may be earned upon satisfaction of performance criteria. To the extent the performance criteria is determined to be satisfied, the actual number of shares earned will vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 17:09 UTC | QUALITY CARE PROPERTIES, INC. QCP · Entity 164714 | GrantOptions (right to buy) · Derivative | 305,842 | $0.00 Strike: $15.73 | $0.00 |
DisclosureSEC source: 0001140361-16-090270 · doc1.xml · derivative · entry 2 Richards C Marc · CIK 0001468881 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,842 Underlying: Common Stock · 305,842 shares Expires 2023-12-15 F1 · derivative.exercise_price: Each stock option represents the right to buy, upon exercise, one share of common stock of Quality Care Properties, Inc. F3 · derivative.exercise_date: The 305,842 stock options are scheduled to vest in full on the third anniversary of the grant date. Vested options are not exercisable until the third anniversary of the grant date. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 17:09 UTC | QUALITY CARE PROPERTIES, INC. QCP · Entity 164714 | GrantOptions (right to buy) · Derivative | 640,000 | $0.00 Strike: $15.73 | $0.00 |
DisclosureSEC source: 0001140361-16-090270 · doc1.xml · derivative · entry 1 Richards C Marc · CIK 0001468881 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 640,000 Underlying: Common Stock · 640,000 shares Expires 2023-12-15 F1 · derivative.exercise_price: Each stock option represents the right to buy, upon exercise, one share of common stock of Quality Care Properties, Inc. F2 · derivative.exercise_date: 320,000 of the 640,000 stock options were fully vested on the grant date. The remaining 320,000 stock options will vest subject to the achievement of performance criteria set forth in the form of option award agreement attached to Mr. Richards' employment agreement. Vested options are not exercisable until the third anniversary of the grant date. Read SEC document |
| November 29, 2016 Filed Dec 1, 2016 16:32 UTC | QUALITY CARE PROPERTIES, INC. QCP · Entity 164714 | GrantRestricted Stock Unit · Derivative | 67,934 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-16-088399 · doc1.xml · derivative · entry 1 Richards C Marc · CIK 0001468881 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,934 Underlying: Common Stock · 67,934 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock of Quality Care Properties, Inc. F2 · derivative.exercise_date: The restricted stock units are scheduled to vest in full on the third anniversary of the date of grant (November 29, 2019). F2 · derivative.expiration_date: The restricted stock units are scheduled to vest in full on the third anniversary of the date of grant (November 29, 2019). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.